Centogene creates more than 220 high-tech jobs in Rostock and builds up an own lab facility
CENTOGENE, founded in 2006, is a world leader in the field of genetic diagnostics for rare hereditary diseases – with the largest test portfolio worldwide.
Receiving samples from over 90 countries allows CENTOGENE a unique insight into epidemiological genetic differences, which is crucial in the interpretation of medical results.
CENTOGENE focuses strictly on offering quality molecular genetic diagnostics, underlined by multiple international accreditations (ISO, CAP, CLIA).
CENTOGENE’s in-depth medical expertise is supported by the application of cutting-edge technologies, including next generation sequencing, whole exome sequencing (CentoXome®), whole genome sequencing, and innovative biomarkers for selected diseases.
5 April 2019
The German Market for Health & Care Technologies